Is there a site predilection for antiretroviral therapy induced HPV lesions in the HIV positive patients?—Multiple case reports

SummaryThe increases incidence of oral human papillomavirus (HPV) in patients infected with the human immunodeficiency virus (HIV) is of concern and is the focus of numerous current research studies. Recent studies have shown an increased risk of oral warts in HIV-infected individuals despite treatment with highly active antiretroviral therapy (HAART). There seems to be a predilection for the labial mucosa as a site specific for occurrence for oral warts. This reports presents a series of case reports documenting the same observation.